Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415694839> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2415694839 endingPage "53" @default.
- W2415694839 startingPage "748" @default.
- W2415694839 abstract "Pilot studies with cyclosporin A (CsA, Sandimmun) in more than 100 patients with Crohn's disease have shown that CsA was more efficient in chronic active disease than in acute attacks. The onset of effect was rapid, usually within the first month, but most patients relapsed during the weeks following the interruption of CsA treatment. These findings were confirmed by a placebo-controlled study (parallel groups) in 71 patients, in whom the rate of improvement at 3 months was 61% on CsA and 33% on placebo. Promising results have also been reported after short-term use of intravenous CsA in severe acute ulcerative colitis. Further controlled trials are still ongoing in order to ascertain the efficacy of CsA administered according to the current safety guidelines (dose less than or equal to 5 mg/kg/day) for a period of one year in patients with chronic active Crohn's disease." @default.
- W2415694839 created "2016-06-24" @default.
- W2415694839 creator A5010760770 @default.
- W2415694839 creator A5024986160 @default.
- W2415694839 date "1991-05-18" @default.
- W2415694839 modified "2023-09-23" @default.
- W2415694839 title "Pharmacology of cyclosporin A (Sandimmun) and clinical experience in inflammatory bowel diseases." @default.
- W2415694839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2057741" @default.
- W2415694839 hasPublicationYear "1991" @default.
- W2415694839 type Work @default.
- W2415694839 sameAs 2415694839 @default.
- W2415694839 citedByCount "2" @default.
- W2415694839 crossrefType "journal-article" @default.
- W2415694839 hasAuthorship W2415694839A5010760770 @default.
- W2415694839 hasAuthorship W2415694839A5024986160 @default.
- W2415694839 hasConcept C126322002 @default.
- W2415694839 hasConcept C142724271 @default.
- W2415694839 hasConcept C204787440 @default.
- W2415694839 hasConcept C27081682 @default.
- W2415694839 hasConcept C2778260677 @default.
- W2415694839 hasConcept C2779134260 @default.
- W2415694839 hasConcept C2779280984 @default.
- W2415694839 hasConcept C2780479503 @default.
- W2415694839 hasConcept C535046627 @default.
- W2415694839 hasConcept C71924100 @default.
- W2415694839 hasConcept C90924648 @default.
- W2415694839 hasConceptScore W2415694839C126322002 @default.
- W2415694839 hasConceptScore W2415694839C142724271 @default.
- W2415694839 hasConceptScore W2415694839C204787440 @default.
- W2415694839 hasConceptScore W2415694839C27081682 @default.
- W2415694839 hasConceptScore W2415694839C2778260677 @default.
- W2415694839 hasConceptScore W2415694839C2779134260 @default.
- W2415694839 hasConceptScore W2415694839C2779280984 @default.
- W2415694839 hasConceptScore W2415694839C2780479503 @default.
- W2415694839 hasConceptScore W2415694839C535046627 @default.
- W2415694839 hasConceptScore W2415694839C71924100 @default.
- W2415694839 hasConceptScore W2415694839C90924648 @default.
- W2415694839 hasIssue "20" @default.
- W2415694839 hasLocation W24156948391 @default.
- W2415694839 hasOpenAccess W2415694839 @default.
- W2415694839 hasPrimaryLocation W24156948391 @default.
- W2415694839 hasRelatedWork W1576589857 @default.
- W2415694839 hasRelatedWork W1830150660 @default.
- W2415694839 hasRelatedWork W1971832703 @default.
- W2415694839 hasRelatedWork W2014346876 @default.
- W2415694839 hasRelatedWork W2106015740 @default.
- W2415694839 hasRelatedWork W2334336446 @default.
- W2415694839 hasRelatedWork W2375484873 @default.
- W2415694839 hasRelatedWork W2912638322 @default.
- W2415694839 hasRelatedWork W3205942131 @default.
- W2415694839 hasRelatedWork W4226137497 @default.
- W2415694839 hasVolume "121" @default.
- W2415694839 isParatext "false" @default.
- W2415694839 isRetracted "false" @default.
- W2415694839 magId "2415694839" @default.
- W2415694839 workType "article" @default.